Á lódáil...

Progress in Immunotherapy for Non-small Cell Lung Cancer

In recent years, the five-year survival rate of patients with advanced stage non-small cell lung cancer (NSCLC) remains low despite recent advances in surgery, irradiation, chemotherapy, and targeted therapy. Immunotherapy which utilizes the immune system to control and eradicate cancer is a viable...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Yan XU, Mengzhao WANG
Formáid: Artigo
Teanga:Chinês
Foilsithe: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2014-01-01
Sraith:Chinese Journal of Lung Cancer
Ábhair:
Rochtain Ar Líne:http://dx.doi.org/10.3779/j.issn.1009-3419.2014.01.06
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!